Canine Atopic Dermatitis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027
The global canine atopic dermatitis market size reached US$ 1.56 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 3.89 Billion by 2027, exhibiting a growth rate (CAGR) of 16.4% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Canine atopic dermatitis (CAD) is an allergic skin disease in dogs caused by allergens, such as pollens, house dust, insect bites, grass and food ingredients. It is an inherited predisposition that generally affects dogs aged between six months to three years. It commonly affects the ventral abdomen, mouth, eyes, interdigital skin, ear pinnae, carpal, elbow and perineal area of the animals. CAD is characterized by various symptoms, such as excessive scratching, inflammation and itching around paws, underarms and face. It can be treated by immuno-suppressants, monoclonal anatomy and glucocorticoids. They can be administered through oral, injectables and topical medications. It is known to be highly prevalent in German shepherds, Labradors, golden retrievers and pugs.
Canine Atopic Dermatitis Market Trends:
The increasing occurrence of CAD in domesticated dogs across the globe is one of the key factors creating a positive outlook for the market. This can be attributed to the changing environmental conditions, rising air pollution levels and prolonged exposure to allergens. Moreover, the increasing concerns and rising awareness among pet owners regarding early symptoms and signs of CAD, such as redness, greasy skin and yeasty smell, are providing a thrust to the market growth. Additionally, the widespread adoption of monoclonal antibodies for the treatment of the disease is favoring the market growth. These antibodies aid in directing the required immune response and calming the spread of the disease. In line with this, the increasing number of veterinary practitioners, hospitals and clinics dedicated to providing improved care for animals is positively impacting the market growth. Other factors, including the implementation of various government initiatives to restrict the usage of off-label human drugs on animals, along with extensive research and development (R&D) in the field of veterinary sciences, are anticipated to drive the market toward growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global canine atopic dermatitis market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on drug class type, route of administration and distribution channel.
Breakup by Drug Class Type:
Glucocorticoids
Immunosuppressants
Monoclonal Antibody
Others
Breakup by Route of Administration:
Topical
Oral
Injectable
Breakup by Distribution Channel:
Veterinary Hospitals
Pet Clinics
Pharmacies and Drugstores
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being AB Science, Bimeda Inc., Bioceltix SA, Boehringer Ingelheim International GmbH, Ceva SantŠ¹ Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Phibro Animal Health Corporation, Toray Industries Inc., Vetoquinol S.A., Virbac and Zoetis Inc.
Key Questions Answered in This Report:
How has the global canine atopic dermatitis market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global canine atopic dermatitis market?
What are the key regional markets?
What is the breakup of the market based on the drug class type?
What is the breakup of the market based on the route of administration?
What is the breakup of the market based on the distribution channel?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global canine atopic dermatitis market and who are the key players?
What is the degree of competition in the industry?
Canine atopic dermatitis (CAD) is an allergic skin disease in dogs caused by allergens, such as pollens, house dust, insect bites, grass and food ingredients. It is an inherited predisposition that generally affects dogs aged between six months to three years. It commonly affects the ventral abdomen, mouth, eyes, interdigital skin, ear pinnae, carpal, elbow and perineal area of the animals. CAD is characterized by various symptoms, such as excessive scratching, inflammation and itching around paws, underarms and face. It can be treated by immuno-suppressants, monoclonal anatomy and glucocorticoids. They can be administered through oral, injectables and topical medications. It is known to be highly prevalent in German shepherds, Labradors, golden retrievers and pugs.
Canine Atopic Dermatitis Market Trends:
The increasing occurrence of CAD in domesticated dogs across the globe is one of the key factors creating a positive outlook for the market. This can be attributed to the changing environmental conditions, rising air pollution levels and prolonged exposure to allergens. Moreover, the increasing concerns and rising awareness among pet owners regarding early symptoms and signs of CAD, such as redness, greasy skin and yeasty smell, are providing a thrust to the market growth. Additionally, the widespread adoption of monoclonal antibodies for the treatment of the disease is favoring the market growth. These antibodies aid in directing the required immune response and calming the spread of the disease. In line with this, the increasing number of veterinary practitioners, hospitals and clinics dedicated to providing improved care for animals is positively impacting the market growth. Other factors, including the implementation of various government initiatives to restrict the usage of off-label human drugs on animals, along with extensive research and development (R&D) in the field of veterinary sciences, are anticipated to drive the market toward growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global canine atopic dermatitis market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on drug class type, route of administration and distribution channel.
Breakup by Drug Class Type:
Glucocorticoids
Immunosuppressants
Monoclonal Antibody
Others
Breakup by Route of Administration:
Topical
Oral
Injectable
Breakup by Distribution Channel:
Veterinary Hospitals
Pet Clinics
Pharmacies and Drugstores
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being AB Science, Bimeda Inc., Bioceltix SA, Boehringer Ingelheim International GmbH, Ceva SantŠ¹ Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Phibro Animal Health Corporation, Toray Industries Inc., Vetoquinol S.A., Virbac and Zoetis Inc.
Key Questions Answered in This Report:
How has the global canine atopic dermatitis market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global canine atopic dermatitis market?
What are the key regional markets?
What is the breakup of the market based on the drug class type?
What is the breakup of the market based on the route of administration?
What is the breakup of the market based on the distribution channel?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global canine atopic dermatitis market and who are the key players?
What is the degree of competition in the industry?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL CANINE ATOPIC DERMATITIS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY DRUG CLASS TYPE
6.1 Glucocorticoids
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Immunosuppressants
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Monoclonal Antibody
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 MARKET BREAKUP BY ROUTE OF ADMINISTRATION
7.1 Topical
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Oral
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Injectable
7.3.1 Market Trends
7.3.2 Market Forecast
8 MARKET BREAKUP BY DISTRIBUTION CHANNEL
8.1 Veterinary Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Pet Clinics
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Pharmacies and Drugstores
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 AB Science
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.2 Bimeda Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Bioceltix SA
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Boehringer Ingelheim International GmbH
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Ceva SantŠ¹ Animale
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Dechra Pharmaceuticals PLC
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.7 Elanco Animal Health Incorporated
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.8 Phibro Animal Health Corporation
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Toray Industries Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Vetoquinol S.A.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.11 Virbac
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Zoetis Inc.
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL CANINE ATOPIC DERMATITIS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY DRUG CLASS TYPE
6.1 Glucocorticoids
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Immunosuppressants
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Monoclonal Antibody
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 MARKET BREAKUP BY ROUTE OF ADMINISTRATION
7.1 Topical
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Oral
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Injectable
7.3.1 Market Trends
7.3.2 Market Forecast
8 MARKET BREAKUP BY DISTRIBUTION CHANNEL
8.1 Veterinary Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Pet Clinics
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Pharmacies and Drugstores
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 AB Science
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.2 Bimeda Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Bioceltix SA
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Boehringer Ingelheim International GmbH
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Ceva SantŠ¹ Animale
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Dechra Pharmaceuticals PLC
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.7 Elanco Animal Health Incorporated
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.8 Phibro Animal Health Corporation
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Toray Industries Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Vetoquinol S.A.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.11 Virbac
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Zoetis Inc.
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis
LIST OF TABLES
Table 1: Global: Canine Atopic Dermatitis Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Canine Atopic Dermatitis Market Forecast: Breakup by Drug Class Type (in Million US$), 2022-2027
Table 3: Global: Canine Atopic Dermatitis Market Forecast: Breakup by Route of Administration (in Million US$), 2022-2027
Table 4: Global: Canine Atopic Dermatitis Market Forecast: Breakup by Distribution Channel (in Million US$), 2022-2027
Table 5: Global: Canine Atopic Dermatitis Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Canine Atopic Dermatitis Market: Competitive Structure
Table 7: Global: Canine Atopic Dermatitis Market: Key Players
Table 1: Global: Canine Atopic Dermatitis Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Canine Atopic Dermatitis Market Forecast: Breakup by Drug Class Type (in Million US$), 2022-2027
Table 3: Global: Canine Atopic Dermatitis Market Forecast: Breakup by Route of Administration (in Million US$), 2022-2027
Table 4: Global: Canine Atopic Dermatitis Market Forecast: Breakup by Distribution Channel (in Million US$), 2022-2027
Table 5: Global: Canine Atopic Dermatitis Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Canine Atopic Dermatitis Market: Competitive Structure
Table 7: Global: Canine Atopic Dermatitis Market: Key Players
LIST OF FIGURES
Figure 1: Global: Canine Atopic Dermatitis Market: Major Drivers and Challenges
Figure 2: Global: Canine Atopic Dermatitis Market: Sales Value (in Billion US$), 2016 & 2021
Figure 3: Global: Canine Atopic Dermatitis Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Canine Atopic Dermatitis Market: Breakup by Drug Class Type (in %), 2021
Figure 5: Global: Canine Atopic Dermatitis Market: Breakup by Route of Administration (in %), 2021
Figure 6: Global: Canine Atopic Dermatitis Market: Breakup by Distribution Channel (in %), 2021
Figure 7: Global: Canine Atopic Dermatitis Market: Breakup by Region (in %), 2021
Figure 8: Global: Canine Atopic Dermatitis (Glucocorticoids) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Canine Atopic Dermatitis (Glucocorticoids) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Canine Atopic Dermatitis (Immunosuppressants) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Canine Atopic Dermatitis (Immunosuppressants) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Canine Atopic Dermatitis (Monoclonal Antibody) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Canine Atopic Dermatitis (Monoclonal Antibody) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Canine Atopic Dermatitis (Other Drug Class Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Canine Atopic Dermatitis (Other Drug Class Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Canine Atopic Dermatitis (Topical) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Canine Atopic Dermatitis (Topical) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Canine Atopic Dermatitis (Oral) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Canine Atopic Dermatitis (Oral) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Canine Atopic Dermatitis (Injectable) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Canine Atopic Dermatitis (Injectable) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Canine Atopic Dermatitis (Veterinary Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Canine Atopic Dermatitis (Veterinary Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Canine Atopic Dermatitis (Pet Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Canine Atopic Dermatitis (Pet Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Canine Atopic Dermatitis (Pharmacies and Drugstores) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Canine Atopic Dermatitis (Pharmacies and Drugstores) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Canine Atopic Dermatitis (Other Distribution Channels) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Canine Atopic Dermatitis (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: North America: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: North America: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: United States: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: United States: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Canada: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Canada: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Asia-Pacific: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Asia-Pacific: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: China: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: China: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Japan: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Japan: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: India: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: India: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: South Korea: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: South Korea: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Australia: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Australia: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Indonesia: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Indonesia: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Others: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Others: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Europe: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Europe: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Germany: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Germany: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: France: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: France: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: United Kingdom: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: United Kingdom: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Italy: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Italy: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Spain: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Spain: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Russia: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Russia: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Others: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Others: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Latin America: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Latin America: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Brazil: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Brazil: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Mexico: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Mexico: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Others: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Others: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Middle East and Africa: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Middle East and Africa: Canine Atopic Dermatitis Market: Breakup by Country (in %), 2021
Figure 78: Middle East and Africa: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Global: Canine Atopic Dermatitis Industry: SWOT Analysis
Figure 80: Global: Canine Atopic Dermatitis Industry: Value Chain Analysis
Figure 81: Global: Canine Atopic Dermatitis Industry: Porter's Five Forces Analysis
Figure 1: Global: Canine Atopic Dermatitis Market: Major Drivers and Challenges
Figure 2: Global: Canine Atopic Dermatitis Market: Sales Value (in Billion US$), 2016 & 2021
Figure 3: Global: Canine Atopic Dermatitis Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Canine Atopic Dermatitis Market: Breakup by Drug Class Type (in %), 2021
Figure 5: Global: Canine Atopic Dermatitis Market: Breakup by Route of Administration (in %), 2021
Figure 6: Global: Canine Atopic Dermatitis Market: Breakup by Distribution Channel (in %), 2021
Figure 7: Global: Canine Atopic Dermatitis Market: Breakup by Region (in %), 2021
Figure 8: Global: Canine Atopic Dermatitis (Glucocorticoids) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Canine Atopic Dermatitis (Glucocorticoids) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Canine Atopic Dermatitis (Immunosuppressants) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Canine Atopic Dermatitis (Immunosuppressants) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Canine Atopic Dermatitis (Monoclonal Antibody) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Canine Atopic Dermatitis (Monoclonal Antibody) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Canine Atopic Dermatitis (Other Drug Class Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Canine Atopic Dermatitis (Other Drug Class Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Canine Atopic Dermatitis (Topical) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Canine Atopic Dermatitis (Topical) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Canine Atopic Dermatitis (Oral) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Canine Atopic Dermatitis (Oral) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Canine Atopic Dermatitis (Injectable) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Canine Atopic Dermatitis (Injectable) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Canine Atopic Dermatitis (Veterinary Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Canine Atopic Dermatitis (Veterinary Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Canine Atopic Dermatitis (Pet Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Canine Atopic Dermatitis (Pet Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Canine Atopic Dermatitis (Pharmacies and Drugstores) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Canine Atopic Dermatitis (Pharmacies and Drugstores) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Canine Atopic Dermatitis (Other Distribution Channels) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Canine Atopic Dermatitis (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: North America: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: North America: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: United States: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: United States: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Canada: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Canada: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Asia-Pacific: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Asia-Pacific: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: China: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: China: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Japan: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Japan: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: India: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: India: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: South Korea: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: South Korea: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Australia: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Australia: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Indonesia: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Indonesia: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Others: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Others: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Europe: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Europe: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Germany: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Germany: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: France: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: France: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: United Kingdom: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: United Kingdom: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Italy: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Italy: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Spain: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Spain: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Russia: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Russia: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Others: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Others: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Latin America: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Latin America: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Brazil: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Brazil: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Mexico: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Mexico: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Others: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Others: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Middle East and Africa: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Middle East and Africa: Canine Atopic Dermatitis Market: Breakup by Country (in %), 2021
Figure 78: Middle East and Africa: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Global: Canine Atopic Dermatitis Industry: SWOT Analysis
Figure 80: Global: Canine Atopic Dermatitis Industry: Value Chain Analysis
Figure 81: Global: Canine Atopic Dermatitis Industry: Porter's Five Forces Analysis
